Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trade Group Urges FDA To Look Beyond Scale In Regulating Nanotechnology

Executive Summary

FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.
Advertisement

Related Content

FDA Nanotech Guidance Draws Industry Comment On Particle Size Criteria
FDA Nanotech Guidance Draws Industry Comment On Particle Size Criteria
FDA Prioritizes New Technologies, Nano Included, In Regulatory Science Plan
FDA Prioritizes New Technologies, Nano Included, In Regulatory Science Plan
ICCR Accepts Four Regulatory Guidance Reports; NGOs Seek Bigger Role
FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
FDA Takes “Property”-Based Approach To Nanotech, Raises Roof To 1 Micron
Advertisement
UsernamePublicRestriction

Register

RS017720

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel